Sr. Clinical Research Scientist
Eli Lilly Canada
Lilly’s Innovation Driven Strategy
An aging population will continue to present challenges to healthcare systems globally. As a company, Lilly is committed to meeting these challenges head-on. This presentation will describe our long-term commitment to discovery in the neurosciences; more specifically, neurodegenerative diseases and pain. We recognize that in order for science to advance, we need to leverage our expertise with that of other organizations. Some examples of existing partnerships will be described.
Dr. Luc Boulay is a Sr. Clinical Research Scientist in Neuroscience Research and Development at Eli Lilly Canada. Prior to joining the pharmaceutical industry, he was an Assistant Professor in the Faculty of Medicine at the University of Ottawa.
Dr. Boulay obtained his B.A.(Hon) in psychology in 1990 at St. Thomas University in Fredericton New Brunswick. He subsequently pursued graduate studies at Carleton University and completed his M.A. (psychology) in 1993. He then obtained a position as a Research Associate within the schizophrenia research unit at the Institute of Mental Health Research in Ottawa; a position he held from 1993 to 2006. During this time, he pursued a doctoral degree at Carleton University in experimental neuropsychology which he completed in 2003. His dissertation research focused on the effects of antipsychotic medicines on neurocognition in persons suffering from schizophrenia. From 2003 to 2005, he completed a two year post-doctoral fellowship at the University of Montreal – L. H-Lafontaine Hospital – where he focused on functional MRI research methodology.
He has been working in various roles within medical affairs in industry since 2006 and has been will Eli Lilly Canada since 2010.
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by Colonel Eli Lilly, who was committed to creating high quality medicines that meet people’s needs, and today we remain true to that mission in all our work. Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and contribute to our communities through philanthropy and volunteerism.
Eli Lilly Canada was established in 1938, the result of a research collaboration with scientists at the University of Toronto which eventually produced the world’s first commercially-available insulin. Lilly Canada now employs more than 500 people across the country, working in the areas of oncology, cardiovascular and endocrine disorders, men’s and women’s health, autoimmunity, neuroscience and diabetes.